With nearly 30 years of experience, Matt Gardella, a biotech lawyer at Mintz, has deep industry knowledge of the life sciences, healthcare and technology sectors. He regularly advises companies, boards of directors, special committees, investment banks and investors in both buy and sell-side M&A, other strategic transactions and defensive measures. In addition, Matt counsels public companies on a broad range of corporate, securities and business-related matters, including capital raising, fiduciary duties, corporate governance, stockholder activism, and SEC reporting. He is consistently recognized by the publication Best Lawyers in America for corporate governance and other areas. For his M&A work, Matt is recognized by Chambers USA: America's Leading Lawyers for Business.